RealFakeLies
Sign in Create account
Trending CLM-9E3397B6

AI-extracted claim

“The FDA's investigational device program granted permission for the Paradromics clinical trial.”
The New York Times by Pam Belluck View original article

Analyzed on 2026-09-26T23:40:32+00:00 · Last updated 2026-09-26

Unverified (Unverified)

Plain language: Insufficient evidence was found to render a verdict.

Credibility score

out of 100

Based on 1 source

Low confidence

01

Original context

Show passage from source article
The Food and Drug Administration’s investigational device program granted permission for the clinical trial, and company officials said they expected Paradromics would need to complete a larger trial before applying for F.D.A. approval of the device in several years.

Extracted from: ‘I Have a Lot to Say’: Brain Implant Helps a Disabled Patient Speak , The New York Times

02

Evidence

1 support 0 contradict 0 context

This analysis is based on a single source. Confidence is low.

The New York Times nytimes.com credibility 0.85 Supports

“The Food and Drug Administration’s investigational device program granted permission for the clinical trial, and company officials said they expected Paradromics would need to complete a larger trial before applying for F.D.A. approval of the device in several years.”

‘I Have a Lot to Say’: Brain Implant Helps a Disabled Patient Speak

Read source

Bias distribution of supporting sources

← Left Center Right →

Mean bias -0.20

05

Community Takes

No Takes have been written on this claim yet. Sign in to write a Take.

06

Metadata

Claim ID CLM-9E3397B6
Slug the-fdas-investigational-device-program-granted-permission-9e3397b6
Origin nytimes.com
Captured 8 d ago
Velocity 0.0/hr
Bias 0.00
Health Business Regulation